Physiotherapy for Arthrofibrosis Following Knee Replacement.

NCT05459259 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 145

Last updated 2022-11-18

No results posted yet for this study

Summary

This research aims to develop an optimal physiotherapy intervention for people with arthrofibrosis (stiffness due to scar tissue) after total knee replacement (TKR). We will develop an optimal intervention by conducting:

1. A review of the evidence to identify what components could be included in the intervention, how effective they are and what outcomes have been measured by the research.
2. Interviews with patients with arthrofibrosis to understand the impact it has on their life and what outcomes are important to them and interviews with healthcare professionals (HCPs) to understand their experiences of treating patients with arthrofibrosis.
3. A Delphi study with a larger group of HCPs and patients to reach a consensus on what the optimal intervention should include. This involves a series of anonymous voting on a range of items that have been generated by the group and the results of the evidence review.
4. A workshop with patients, HCPs and health-care commissioners to finalise the intervention. During the workshop we will present our findings and work in small groups to agree the intervention

Conditions

  • Arthroplasty Complications
  • Fibrosis
  • Knee Joint Contracture

Interventions

OTHER

Interviews and Delphi Survey

no intervention delivered

Sponsors & Collaborators

  • King's College London

    collaborator OTHER
  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV
  • University of Nottingham

    lead OTHER

Principal Investigators

  • Michelle C Hall, PhD · University of Nottingham

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-03
Primary Completion
2023-08-30
Completion
2023-08-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05459259 on ClinicalTrials.gov